What are some recent advancements in proteomics-driven pancreatic oncology research

In a recent narrative review published inProteomes,researchers reviewed the application of proteomics-driven biomarkers for early detection, diagnosis, and treatment of pancreatic cancer.A

Updated on: October 30,2023

What are some recent advancements in proteomics-driven pancreatic oncology research

In a recent narrative review published inProteomes,researchers reviewed the application of proteomics-driven biomarkers for early detection, diagnosis, and treatment of pancreatic cancer.A

Updated on:October 30,2023

FDA advisors to weigh new gene therapy for sickle cell anemia

by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera

Updated on: January 04,2024

FDA advisors to weigh new gene therapy for sickle cell anemia

by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera

Updated on:January 04,2024

Novel cell 'switches' found to promote lung cancer growth, treatment resistance

by Melissa Rohman,Northwestern UniversitySCLC cell lines have divergent gene regulatory networks and phenotypes. (A) Hierarchical clustering was performed using 53 SCLC cell lines. Silhouette wi

Updated on: December 21,2023

Novel cell 'switches' found to promote lung cancer growth, treatment resistance

by Melissa Rohman,Northwestern UniversitySCLC cell lines have divergent gene regulatory networks and phenotypes. (A) Hierarchical clustering was performed using 53 SCLC cell lines. Silhouette wi

Updated on:December 21,2023

Plugging immune cell leakage from tumors could improve skin cancer treatment

byNYU Langone HealthMelanoma. Credit: Wikimedia Commons/National Cancer InstituteThe number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked th

Updated on: December 20,2023

Plugging immune cell leakage from tumors could improve skin cancer treatment

byNYU Langone HealthMelanoma. Credit: Wikimedia Commons/National Cancer InstituteThe number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked th

Updated on:December 20,2023

New study reveals how blood cancer cells escape the immune system's natural killer cells

byUniversity of HelsinkiGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.008The advent of T-cell therapies, where cells of the immune system are directed towa

Updated on: January 26,2024

New study reveals how blood cancer cells escape the immune system's natural killer cells

byUniversity of HelsinkiGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.008The advent of T-cell therapies, where cells of the immune system are directed towa

Updated on:January 26,2024

Lung cancer screening guidelines perpetuate racial disparities, study finds

Lung cancer screening guidelines perpetuate racial disparities, study findsby Krista Conger,Stanford UniversityRacial Disparities in the Eligibility-Incidence (E-I) Ratio Through the US Preventi

Updated on: October 30,2023

Lung cancer screening guidelines perpetuate racial disparities, study finds

Lung cancer screening guidelines perpetuate racial disparities, study findsby Krista Conger,Stanford UniversityRacial Disparities in the Eligibility-Incidence (E-I) Ratio Through the US Preventi

Updated on:October 30,2023

Research reveals how synthesized plankton molecules inhibit cancer proteins

by Justin Jackson , Medical Xpressa, Chemical structure of reported PA and PB (in beige), and the revised structure of PB (in blue) in this work. b, A retrosynthesis targeting a minimally oxidized int

Updated on: October 14,2023

Research reveals how synthesized plankton molecules inhibit cancer proteins

by Justin Jackson , Medical Xpressa, Chemical structure of reported PA and PB (in beige), and the revised structure of PB (in blue) in this work. b, A retrosynthesis targeting a minimally oxidized int

Updated on:October 14,2023

Acute leukemia patients treated with common therapy have increased risk for heart failure

byPerelman School of Medicine at the University of PennsylvaniaPatients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines are at a heigh

Updated on: December 22,2023

Acute leukemia patients treated with common therapy have increased risk for heart failure

byPerelman School of Medicine at the University of PennsylvaniaPatients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines are at a heigh

Updated on:December 22,2023

How a patient partnership is propelling cancer research

by Leah Eisenstadt,Broad Institute of MIT and HarvardCount Me In Director Nikhil Wagle and Strategic Advisor Corrie Painter. Credit: Broad Institute of MIT and HarvardIn the fall of 2018, cancer

Updated on: December 19,2023

How a patient partnership is propelling cancer research

by Leah Eisenstadt,Broad Institute of MIT and HarvardCount Me In Director Nikhil Wagle and Strategic Advisor Corrie Painter. Credit: Broad Institute of MIT and HarvardIn the fall of 2018, cancer

Updated on:December 19,2023

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

Updated on: December 17,2023

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

by Impact Journals LLCEvaluation of the toxicity of MK256 in vivo. Credit:Oncotarget(2022). DOI: 10.18632/oncotarget.28305A new research paper titled "MK256 is a novel CDK8 inhibitor

Updated on:December 17,2023

Missing a Rare Cause of Hereditary Cancer

New research fromCedars-Sinai Cancerinvestigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common caus

Updated on: November 07,2023

Missing a Rare Cause of Hereditary Cancer

New research fromCedars-Sinai Cancerinvestigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common caus

Updated on:November 07,2023

New antibody shows strong potential as treatment against pancreatic cancer

New antibody shows strong potential as treatment against pancreatic cancerbyTranslational Genomics Research InstituteSIWA318H treatment depletes p16INK4apositive cells and reduces αSMA exp

Updated on: October 30,2023

New antibody shows strong potential as treatment against pancreatic cancer

New antibody shows strong potential as treatment against pancreatic cancerbyTranslational Genomics Research InstituteSIWA318H treatment depletes p16INK4apositive cells and reduces αSMA exp

Updated on:October 30,2023